NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.55B
1-Year Est. Return 16.8%
This Quarter Est. Return
1 Year Est. Return
+16.8%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.93B
AUM Growth
-$321M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$150M
2
+$16M
3
+$5.46M
4
FOLD icon
Amicus Therapeutics
FOLD
+$5.37M
5
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$4.57M

Top Sells

1
+$53M
2
+$43.1M
3
+$33.7M
4
INZY
Inozyme Pharma
INZY
+$31.8M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$26.9M

Sector Composition

1 Healthcare 57.28%
2 Financials 8.56%
3 Technology 7.59%
4 Consumer Discretionary 1.65%
5 Communication Services 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$16M 0.83%
+534,085
27
$14.4M 0.75%
2,530,585
28
$11.5M 0.59%
498,528
+198,528
29
$8.97M 0.46%
99,912
30
$8.89M 0.46%
247,047
+60,000
31
$8.63M 0.45%
468,902
32
$8.62M 0.45%
2,170,100
33
$8.56M 0.44%
1,403,370
34
$8.27M 0.43%
711,945
+252,655
35
$8.12M 0.42%
147,557
36
$7.63M 0.39%
283,769
-39,231
37
$7.43M 0.38%
418,943
+307,799
38
$6.72M 0.35%
442,550
39
$6.58M 0.34%
128,544
-28,871
40
$6.33M 0.33%
555,186
41
$5.86M 0.3%
72,212
42
$4.96M 0.26%
21,300
-24,851
43
$4.72M 0.24%
25,000
-9,679
44
$4.62M 0.24%
16,667
-44,030
45
$4.17M 0.22%
761,205
46
$2.25M 0.12%
255,000
47
$2.13M 0.11%
+114,330
48
$1.53M 0.08%
40,000
-1,382,953
49
$20K ﹤0.01%
2,703
50
– –
-422,382
1
2
3